It involved providing the licensed Meningococcal B vaccine free to about 35,000 adolescents enrolled in years 10, 11 and 12 in schools across South Australia (SA), to help determine the impact of immunising large community groups against the disease.
During the COVID-19 pandemic, Prof. Helen provided advice to the state’s Health Minister and was cited as one of Australia’s leading vaccination experts. Beginning in September 2020, she was the co-investigator at the University of Sydney in a Phase I human trial of a novel DNA-based COVID-19 vaccine developed by BioNet and Technovalia that could be administered without using a needle.
She is also part of a University of Queensland research team seeking to improve primary healthcare services for Aboriginal and Torres Strait Islander peoples and is leading a study to provide free meningococcal B vaccinations to Northern Territory residents as she studies whether the vaccine can also provide protection against gonorrhoea.
In recognition of Prof. Helen’s research leadership, she was awarded 2022 SA Australian of the Year and 2022 SA Woman of the Year. In 2021 she was made a Fellow of the Australian Academy Health and Medical Sciences.
She is Professor in Vaccinology in the Adelaide Medical School, and Deputy Director, Clinical and Translational Research for the Robinson Research Institute at The University of Adelaide. She also holds the position of Senior Medical Practitioner and Medical Director, Vaccinology and Immunology Research Trials Unit (VIRTU), in the Department of Paediatrics at the Women’s and Children’s Hospital. In 2022 she was appointed as the inaugural Clinical Research Director of the Women’s and Children’s Health Network in Adelaide.
Bu hikaye BioSpectrum Asia dergisinin December 2022 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye BioSpectrum Asia dergisinin December 2022 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
Australia develops AI sperm checker to enhance IVF success
Engineers in Australia have developed an artificial intelligence (AI) technology that accurately assesses the quality of live sperm in seconds, removing the need for invasive procedures that compromise sperm viability in vitro fertilisation (IVF) treatments.
Singapore discovers new fungus type, a possible global public health threat
Researchers from the Singapore General Hospital (SGH), A*STAR’s Genome Institute of Singapore (GIS) and Yong Loo Lin School of Medicine at National University of Singapore (NUS Medicine) have discovered a new clade (or type) of Candida auris, bringing the number of clades known globally to a total of six.
Singapore strengthens focus on computational biology
Singapore's National Quantum Office (NQO), Agency for Science, Technology and Research (A*STAR), National University of Singapore (NUS), National Supercomputing Centre (NSCC) and Quantinuum have signed a Memorandum of Understanding (MoU), enabling access to Quantinuum's advanced quantum computer, and to explore and collaborate on quantum computing use cases, focusing on computational biology.
Global scientists explore innovative tech to rapidly make new vaccine antigens
Researchers in the US are pursuing pioneering technology that may be able to rapidly create safe and effective vaccines against deadly epidemic and pandemic diseases that are more stable and less expensive than current vaccines.
Korea develops micro-structured artificial lung model using bioprinting technology
A team of Korean researchers has made a breakthrough that will greatly enhance the efficiency of respiratory disease research, garnering attention.
Philips names Ling Liu as Chief Region Leader of Greater China
Royal Philips, a global leader in health technology, has announced the appointment of Ling Liu as the Chief Region Leader of Philips Greater China.
PW Skills launches School of Healthcare to solve India's critical shortage of medical professionals
PW Skills, the upskilling vertical of Physics Wallah (PW) has announced the launch of School of Healthcare across five cities in India, namely, Noida, Indore, Lucknow, Patna and Delhi.
Australian biotech incubator Proto Axiom announces $20 M Series B first close
Proto Axiom, the Australian biomedical technology incubator, has announced a $20 million first close of its targeted $30 million Series B, to bolster Australia's biotechnology sector through increased intellectual property (IP) retention.
Biogen, Beckman Coulter and Fujirebio to develop new tests for tau pathology
Biogen Inc., Beckman Coulter, Inc. (both based in the US) and Japan-based Fujirebio have announced a collaboration to potentially identify and develop blood-based biomarkers for tau pathology in the brain and to potentially clinically advance and potentially commercialise new tests for tau pathology in Alzheimer’s disease (AD).
Pfizer upgrades pharma production plant in Melbourne
Australia is stepping up to the global fight against antimicrobial resistance, as Pfizer Australia announces a major upgrade to its manufacturing facility in Melbourne, Victoria.